Copyright Reports & Markets. All rights reserved.

USA Non-Invasive Prenatal Testing Devices Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Non-Invasive Prenatal Testing Devices Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Type I Market Performance (Volume)
      • 2.1.2 Type II Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Type I Market Performance (Value)
      • 2.1.2 Type II Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospitals Market Performance (Volume)
      • 3.1.2 Clinics Market Performance (Volume)
      • 3.1.3 Research Laboratories Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 BGI Genomics
      • 4.1.1 BGI Genomics Profiles
      • 4.1.2 BGI Genomics Product Information
      • 4.1.3 BGI Genomics Non-Invasive Prenatal Testing Devices Business Performance
      • 4.1.4 BGI Genomics Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.2 Illumina
      • 4.2.1 Illumina Profiles
      • 4.2.2 Illumina Product Information
      • 4.2.3 Illumina Non-Invasive Prenatal Testing Devices Business Performance
      • 4.2.4 Illumina Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.3 LifeCodexx
      • 4.3.1 LifeCodexx Profiles
      • 4.3.2 LifeCodexx Product Information
      • 4.3.3 LifeCodexx Non-Invasive Prenatal Testing Devices Business Performance
      • 4.3.4 LifeCodexx Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.4 Natera
      • 4.4.1 Natera Profiles
      • 4.4.2 Natera Product Information
      • 4.4.3 Natera Non-Invasive Prenatal Testing Devices Business Performance
      • 4.4.4 Natera Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.5 Sequenom
      • 4.5.1 Sequenom Profiles
      • 4.5.2 Sequenom Product Information
      • 4.5.3 Sequenom Non-Invasive Prenatal Testing Devices Business Performance
      • 4.5.4 Sequenom Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.6 Ariosa Diagnostics
      • 4.6.1 Ariosa Diagnostics Profiles
      • 4.6.2 Ariosa Diagnostics Product Information
      • 4.6.3 Ariosa Diagnostics Non-Invasive Prenatal Testing Devices Business Performance
      • 4.6.4 Ariosa Diagnostics Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.7 Berry Genomics
      • 4.7.1 Berry Genomics Profiles
      • 4.7.2 Berry Genomics Product Information
      • 4.7.3 Berry Genomics Non-Invasive Prenatal Testing Devices Business Performance
      • 4.7.4 Berry Genomics Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.8 CombiMatrix
      • 4.8.1 CombiMatrix Profiles
      • 4.8.2 CombiMatrix Product Information
      • 4.8.3 CombiMatrix Non-Invasive Prenatal Testing Devices Business Performance
      • 4.8.4 CombiMatrix Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.9 F. Hoffmann-La Roche
      • 4.9.1 F. Hoffmann-La Roche Profiles
      • 4.9.2 F. Hoffmann-La Roche Product Information
      • 4.9.3 F. Hoffmann-La Roche Non-Invasive Prenatal Testing Devices Business Performance
      • 4.9.4 F. Hoffmann-La Roche Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.10 Genpharm Services
      • 4.10.1 Genpharm Services Profiles
      • 4.10.2 Genpharm Services Product Information
      • 4.10.3 Genpharm Services Non-Invasive Prenatal Testing Devices Business Performance
      • 4.10.4 Genpharm Services Non-Invasive Prenatal Testing Devices Business Development and Market Status
    • 4.11 Laboratory Corporation of America Holdings
    • 4.12 LifeLabs Genetics
    • 4.13 LifeCodexx
    • 4.14 Natera
    • 4.15 Sequenom

    5 Market Performance for Manufacturers

    • 5.1 USA Non-Invasive Prenatal Testing Devices Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 USA Non-Invasive Prenatal Testing Devices Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 USA Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 USA Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Northeast Market Performance for Manufacturers
      • 6.1.1 Northeast Non-Invasive Prenatal Testing Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Northeast Non-Invasive Prenatal Testing Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Northeast Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Northeast Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Midwest Market Performance for Manufacturers
      • 6.2.1 Midwest Non-Invasive Prenatal Testing Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Midwest Non-Invasive Prenatal Testing Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Midwest Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Midwest Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Market Performance for Manufacturers
      • 6.3.1 South Non-Invasive Prenatal Testing Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Non-Invasive Prenatal Testing Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 West Market Performance for Manufacturers
      • 6.4.1 West Non-Invasive Prenatal Testing Devices Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 West Non-Invasive Prenatal Testing Devices Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 West Non-Invasive Prenatal Testing Devices Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 West Non-Invasive Prenatal Testing Devices Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration

    7 USA Non-Invasive Prenatal Testing Devices Market Performance (Sales Point)

    • 7.1 USA Non-Invasive Prenatal Testing Devices Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 USA Non-Invasive Prenatal Testing Devices Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 USA Non-Invasive Prenatal Testing Devices Price (USD/Unit) by Regions 2013-2018
    • 7.4 USA Non-Invasive Prenatal Testing Devices Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 USA Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Northeast Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Midwest Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 West Non-Invasive Prenatal Testing Devices Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospitals Industry
    • 11.2 Clinics Industry
    • 11.3 Research Laboratories Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 USA Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 USA Non-Invasive Prenatal Testing Devices Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Northeast Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Midwest Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 West Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Non-Invasive Prenatal Testing Devices Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hospitals Sales and and Growth Rate 2019-2024
      • 12.4.3 Clinics Sales and and Growth Rate 2019-2024
      • 12.4.4 Research Laboratories Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 USA Non-Invasive Prenatal Testing Devices Price (USD/Unit) Trend 2019-2024
      • 12.5.2 USA Non-Invasive Prenatal Testing Devices Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Non-Invasive Prenatal Testing Devices for these regions, from 2012 to 2023 (forecast), including
    Northeast
    Midwest
    South
    West

    USA Non-Invasive Prenatal Testing Devices market competition by top manufacturers/players, with Non-Invasive Prenatal Testing Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    BGI Genomics
    Illumina
    LifeCodexx
    Natera
    Sequenom
    Ariosa Diagnostics
    Berry Genomics
    CombiMatrix
    F. Hoffmann-La Roche
    Genpharm Services
    Laboratory Corporation of America Holdings
    LifeLabs Genetics
    Quest Diagnostics
    Safembryo
    Sengenics

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Type I
    Type II

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Non-Invasive Prenatal Testing Devices for each application, including
    Hospitals
    Clinics
    Research Laboratories

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now